Literature DB >> 19184472

Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women.

Mina Ha1, Joohon Sung, Yun-Mi Song.   

Abstract

OBJECTIVE: To evaluate an association between serum total cholesterol level and breast cancer risk, for which inconsistent findings have been reported in spite of the role of serum cholesterol as a precursor to a breast cancer-related sex steroid hormone.
METHODS: Postmenopausal Korean women (n = 170,374), categorized into four groups by quartiles of cholesterol level, were followed up for occurrence of breast cancer from 1993 to 2003. Relative risks were assessed by Cox proportional hazard analysis.
RESULTS: A positive association between cholesterol level and breast cancer risk was found with 31% greater age-adjusted risk of breast cancer in the highest cholesterol group (>or=5.95 mmol/l) than that in the lowest cholesterol group (<4.63 mmol/l). The strength of association was reduced slightly but persisted after the adjustment for reproductive and behavioral covariates. However, the association further attenuated and the positive trend was no longer significant when BMI was additionally adjusted (p-trend, 0.0684). Stratified analysis by BMI showed that the risk of breast cancer increased with increasing cholesterol level only in normal BMI (<25 kg/m(2)) group, but the interaction term was not significant.
CONCLUSION: Serum total cholesterol level is not associated with the risk of breast cancer in postmenopausal Korean women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184472     DOI: 10.1007/s10552-009-9301-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  16 in total

Review 1.  The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.

Authors:  Erik R Nelson
Journal:  Mol Cell Endocrinol       Date:  2017-09-15       Impact factor: 4.102

2.  Metabolic conditions and breast cancer risk among Los Angeles County Filipina Americans compared with Chinese and Japanese Americans.

Authors:  Anna H Wu; Cheryl Vigen; Lesley M Butler; Chiu-Chen Tseng
Journal:  Int J Cancer       Date:  2017-09-06       Impact factor: 7.396

3.  Total cholesterol and cancer risk in a large prospective study in Korea.

Authors:  Cari M Kitahara; Amy Berrington de González; Neal D Freedman; Rachel Huxley; Yejin Mok; Sun Ha Jee; Jonathan M Samet
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

4.  The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.

Authors:  D P McDonnell; C-Y Chang; E R Nelson
Journal:  Climacteric       Date:  2014-10-16       Impact factor: 3.005

Review 5.  The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer.

Authors:  Amy E Baek; Erik R Nelson
Journal:  Horm Cancer       Date:  2016-03-28       Impact factor: 3.869

6.  Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.

Authors:  Jennifer C Melvin; Lars Holmberg; Sabine Rohrmann; Massimo Loda; Mieke Van Hemelrijck
Journal:  J Cancer Epidemiol       Date:  2013-01-20

Review 7.  The Tumor Promotional Role of Adipocytes in the Breast Cancer Microenvironment and Macroenvironment.

Authors:  Jamie J Bernard; Elizabeth A Wellberg
Journal:  Am J Pathol       Date:  2021-02-24       Impact factor: 5.770

8.  High-density lipoprotein cholesterol, obesity, and mammographic density in Korean women: the Healthy Twin study.

Authors:  Joohon Sung; Yun-Mi Song; Jennifer Stone; Kayoung Lee; Sun-Young Kim
Journal:  J Epidemiol       Date:  2010-11-06       Impact factor: 3.211

9.  Noncommunicable diseases: current status of major modifiable risk factors in Korea.

Authors:  Hyeon Chang Kim; Sun Min Oh
Journal:  J Prev Med Public Health       Date:  2013-07-31

10.  Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.

Authors:  Catarina Rodrigues Dos Santos; Isabel Fonseca; Sérgio Dias; J C Mendes de Almeida
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.